Table 3.
Comparison Between Patients with and without Sarcopenia Regarding Possible Risk Factors
| Sarcopenia Group n=42 | Non-Sarcopenia Group n=55 | p-value | |
|---|---|---|---|
| Age (years) | 55.6±5.0 | 51.7±6.2 | 0.001 |
| Sex (male/female) | 28/14 | 44/11 | 0.137 |
| Body mass index (kg/m2) | 26.5±3.5 | 25.9±3.1 | 0.346 |
| Diabetes mellitus (yes/no) | 9/33 | 13/42 | 0.797 |
| Hypertension (yes/no) | 13/29 | 18/37 | 0.853 |
| Dyslipidemia (yes/no) | 9/33 | 10/45 | 0.690 |
| Disease Characteristics | |||
| Tumor diameter (cm) | 2.8±0.8 | 2.7±0.7 | 0.687 |
| Child Class (A/B) | 27/15 | 37/18 | 0.758 |
| MELD score | 10 (8–15) | 10 (8–13) | 0.365 |
| Laboratory results | |||
| Hemoglobin concentration (gm/dL) | 11.2±1.2 | 11.2±1.5 | 0.993 |
| White cell count (x103/mm3) | 6.3±2.2 | 6.2±1.6 | 0.855 |
| Platelet count (x103/mm3) | 174±61 | 180±57 | 0.642 |
| Serum Albumin (g/dL) | 3.4±0.3 | 3.4±0.4 | 0.841 |
| Serum Bilirubin (mg/dL) | 1.6±0.3 | 1.7±0.4 | 0.005 |
| Alanine aminotransferase (U/L) | 49.1±13.6 | 50.5±14.8 | 0.637 |
| Aspartate aminotransferase (U/L) | 60.3±12.5 | 58.8±10.9 | 0.525 |
| International normalized ratio | 1.5±0.2 | 1.4±0.2 | 0.258 |
| Serum creatinine (mg/dL) | 1.1±0.3 | 1.1±0.3 | 0.669 |
| Alpha-fetoprotein (ng/mL) | 154 (45–432) | 165 (20–301) | 0.626 |
Note: Data are expressed as mean±SD, or median (range).
Abbreviation: MELD, Model for End-stage Liver Disease.